{"id":"W4403584506","doi":"10.1177/1759720x241283340","title":"What have we learnt from the inhibition of IL-6 in RA and what are the clinical opportunities for patient outcomes?","year":2024,"lang":"en","type":"review","venue":"Therapeutic Advances in Musculoskeletal Disease","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"ca_institutions":"Western University","funders":"UCB Pharma; Sanofi Genzyme; Medac; Nordic Pharma Group; Swedish Orphan Biovitrum; Biogen; Celgene; Gilead Sciences; Celltrion; Sanofi; Fresenius Kabi; Amgen; Pfizer; Eli Lilly and Company; GlaxoSmithKline","keywords":"Medicine; Tocilizumab; Rheumatoid arthritis; Inflammation; Disease; Cytokine; Pathogenesis; Immunology; Bioinformatics; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007841145,0.0004800659,0.001608963,0.0001761937,0.00009055439,0.0002330995,0.0002310828,0.0001570131,0.00003657036],"category_scores_gemma":[0.0002425537,0.0002357913,0.0008750588,0.0001887748,0.0009815295,0.0009321616,0.0001683956,0.0007695211,0.000007352897],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007580483,"about_ca_system_score_gemma":0.0003258029,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001251049,"about_ca_topic_score_gemma":0.0001095342,"domain_scores_codex":[0.9965134,0.0008400214,0.001188162,0.0005443291,0.0005118988,0.0004021351],"domain_scores_gemma":[0.9967278,0.001981331,0.0003804277,0.0006187979,0.00008008687,0.0002115244],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002610221,0.0002273543,0.0003378538,0.006715144,0.0002514028,0.00006819268,0.0004323535,0.000001217326,8.870263e-8,0.0004226156,0.00003018941,0.9912525],"study_design_scores_gemma":[0.001408638,0.0003707013,0.0006735001,0.07170799,0.0004041341,0.00000510989,0.01987906,0.00005964563,1.911821e-7,0.01246338,0.8927147,0.0003129776],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00568995,0.9847991,0.00002051432,0.005524309,0.000604281,0.003056899,0.0002700249,0.00002307687,0.00001183501],"genre_scores_gemma":[0.009320091,0.9886696,0.00002145008,0.0005773394,0.0001042896,0.00093917,0.0002358541,0.00007199041,0.00006017627],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9909396,"threshold_uncertainty_score":0.9615288,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1017056085461307,"score_gpt":0.4238500724344531,"score_spread":0.3221444638883224,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}